Lisa Gill
Stock Analyst at JP Morgan
(3.18)
# 1,103
Out of 4,960 analysts
139
Total ratings
46.15%
Success rate
1.85%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $418 → $310 | $307.42 | +0.84% | 9 | Aug 6, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $472 → $384 | $316.55 | +21.31% | 5 | Jul 22, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $21.97 | +45.65% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $180.23 | +5.42% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $23.65 | +26.85% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $28.74 | +42.66% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $15.84 | +7.32% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $299.51 | -14.53% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $71.30 | +13.60% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $148.10 | -2.09% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $292.60 | +2.87% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $12.05 | +49.38% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.74 | +33.69% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $23.64 | +18.44% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $12.07 | +24.28% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.68 | +17.19% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $5.05 | +256.44% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $689.45 | -4.13% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $304.35 | +43.91% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $12.98 | +38.67% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $174.44 | +126.44% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $278.18 | -12.65% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $185.58 | +0.23% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $179.50 | -22.01% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $404.97 | -18.02% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.56 | +119.30% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.33 | +576.69% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $7.47 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.55 | +44.14% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $69.60 | +19.25% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $29.41 | +233.22% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $25.14 | - | 4 | Dec 19, 2017 |
UnitedHealth Group
Aug 6, 2025
Maintains: Overweight
Price Target: $418 → $310
Current: $307.42
Upside: +0.84%
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $316.55
Upside: +21.31%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $21.97
Upside: +45.65%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $180.23
Upside: +5.42%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.65
Upside: +26.85%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $28.74
Upside: +42.66%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $15.84
Upside: +7.32%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $299.51
Upside: -14.53%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $71.30
Upside: +13.60%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $148.10
Upside: -2.09%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $292.60
Upside: +2.87%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $12.05
Upside: +49.38%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.74
Upside: +33.69%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $23.64
Upside: +18.44%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $12.07
Upside: +24.28%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.68
Upside: +17.19%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $5.05
Upside: +256.44%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $689.45
Upside: -4.13%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $304.35
Upside: +43.91%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $12.98
Upside: +38.67%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $174.44
Upside: +126.44%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $278.18
Upside: -12.65%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $185.58
Upside: +0.23%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $179.50
Upside: -22.01%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $404.97
Upside: -18.02%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.56
Upside: +119.30%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.33
Upside: +576.69%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $7.47
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.55
Upside: +44.14%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $69.60
Upside: +19.25%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $29.41
Upside: +233.22%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $25.14
Upside: -